Other tetraspanin proteins including CD63, CD73, CD151, and Tspan8 have also been shown to modulate the EMT process and tumor progression in colorectal cancer, gastric cancer, melanoma, and renal cell carcinoma (38–41). Here, CD63 is linked to renal cell carcinoma.